Literature DB >> 14648260

Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation.

Shigehiro Inoue1, Motoyuki Horii, Takeshi Asano, Mikihiro Fujioka, Taku Ogura, Masahiko Shibatani, Wook-Choel Kim, Masako Nakagawa, Takashi Tanaka, Yoshio Hirota, Toshikazu Kubo.   

Abstract

We investigated risk factors for osteonecrosis of the femoral head (ONF) in renal transplant recipients, who are susceptible to the disease. Among 287 renal transplant recipients, 18 ONF patients with enough data were included, and 18 age- and sex-matched recipients without ONF were nominated as reference cases. Risk factors were analyzed using a conditional logistic regression method. There were no differences between the ONF patients and the reference cases regarding the types of immunosuppressant or the donor (living or cadaveric, father or mother, matching blood type and human leukocyte antigens). The daily oral steroid dosage (prednisolone 25.0 mg/day or more) and blood urea nitrogen level 2 months after transplantation were the only factors with relevance to the occurrence of ONF. We propose that oral steroid dosages should be low or reduced after renal transplantation, and acute rejection should be controlled with pulsed therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648260     DOI: 10.1007/s00776-003-0716-9

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  17 in total

1.  Estimation of minimum whole-blood tacrolimus concentration for therapeutic drug monitoring with plasma prednisolone concentration: A retrospective cohort study in Japanese kidney transplant recipients.

Authors:  Nobuyuki Sugioka; Akiko Matsushita; Takatoshi Kokuhu; Masahiko Okamoto; Norio Yoshimura; Yukako Ito; Nobuhito Shibata; Kanji Takada
Journal:  Curr Ther Res Clin Exp       Date:  2006-03

Review 2.  Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Authors:  Troels K Bergmann; Katherine A Barraclough; Katie J Lee; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

Review 3.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

4.  Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients.

Authors:  Masaki Takao; Takashi Sakai; Takashi Nishii; Hideki Yoshikawa; Shiro Takahara; Nobuhiko Sugano
Journal:  Rheumatol Int       Date:  2009-10-28       Impact factor: 2.631

Review 5.  Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review.

Authors:  Katharine Shim; Mary J MacKenzie; Eric Winquist
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Conversion total hip arthroplasty: Primary or revision total hip arthroplasty.

Authors:  Ran Schwarzkopf; Mahta Baghoolizadeh
Journal:  World J Orthop       Date:  2015-11-18

7.  The role of hypercoagulability in the development of osteonecrosis of the femoral head.

Authors:  Marios G Lykissas; Ioannis D Gelalis; Ioannis P Kostas-Agnantis; Georgios Vozonelos; Anastasios V Korompilias
Journal:  Orthop Rev (Pavia)       Date:  2012-05-29

Review 8.  Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant's Recipients: A Systematic Review.

Authors:  Adla B Hassan; Kanz W Ghalib; Haitham A Jahrami; Amgad E El-Agroudy
Journal:  Medicina (Kaunas)       Date:  2021-05-23       Impact factor: 2.430

9.  The pathogenesis of nontraumatic osteonecrosis.

Authors:  Jesse Seamon; Thomas Keller; Jamal Saleh; Quanjun Cui
Journal:  Arthritis       Date:  2012-11-08

10.  Short term clinical outcome of a porous tantalum implant for the treatment of advanced osteonecrosis of the femoral head.

Authors:  Mélissa Nadeau; Chantal Séguin; John S Theodoropoulos; Edward J Harvey
Journal:  Mcgill J Med       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.